Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26856474 |
US |
70 | 2 |
Spinal stenosis, Gait disturbance, Arthralgia, |
||||
DUPILUMAB, |
||||
| 502 | 26856522 |
US |
62 | 1 |
Atrial fibrillation, Prostate cancer, Multiple fractures, Benign neoplasm, Foot fracture, Gait disturbance, |
||||
TESTOSTERONE CYPIONATE, |
||||
| 503 | 26856971 |
US |
80 | 2 |
Accident, Fall, Gait disturbance, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CALCIUM, VENLAFAXINE HYDROCHLORIDE, EZETIMIBE, FERROUS SULFATE, FOLIC ACID, ORPHENADRINE CITRATE, OXYBUTYNIN CHLORIDE, PREDNISONE, |
||||
| 504 | 26860343 |
67 | 1 | |
Dyspnoea, Heart rate increased, Electrocardiogram abnormal, Gait disturbance, |
||||
RELUGOLIX, LISINOPRIL, |
||||
| 505 | 26861348 |
74 | 2 | |
Diabetes mellitus, Weight decreased, Dry mouth, Oral pain, Oropharyngeal pain, Gait disturbance, Activities of daily living decreased, Therapy cessation, |
||||
ALPELISIB, |
||||
| 506 | 26846760 |
US |
62 | 2 |
Plasma cell myeloma, Pneumonia fungal, Gait disturbance, Immunoglobulins abnormal, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, LENALIDOMIDE, |
||||
| 507 | 26846897 |
60 | 2 | |
Renal tubular necrosis, Fall, Tachycardia, Hypotension, Gait disturbance, Mental status changes, Drug interaction, |
||||
VALSARTAN, VALSARTAN ORAL, AMLODIPINE, EMPAGLIFLOZIN, |
||||
| 508 | 26847107 |
US |
1 | |
Gallbladder disorder, Hemiplegia, Gait disturbance, Dizziness, Tooth disorder, Inner ear disorder, Stomatitis, Headache, Vertigo, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, |
||||
| 509 | 26847230 |
|||
Renal tubular necrosis, Fall, Tachycardia, Hypotension, Gait disturbance, Mental status changes, Drug interaction, |
||||
VALSARTAN, VALSARTAN ORAL, AMLODIPINE, EMPAGLIFLOZIN, |
||||
| 510 | 26847355 |
US |
83 | 2 |
Pain, Gait disturbance, Injury associated with device, Device issue, Product dose omission issue, |
||||
INSULIN GLARGINE, |
||||
| 511 | 26847382 |
US |
80 | 1 |
Aphasia, Movement disorder, Fall, Gait disturbance, Underdose, |
||||
PIMAVANSERIN TARTRATE, MEMANTINE, MEMANTINE HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE, QUETIAPINE, |
||||
| 512 | 26847882 |
US |
2 | |
Gait disturbance, Rhinorrhoea, |
||||
DUPILUMAB, DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZELASTINE HYDROCHLORIDE, AZELASTINE, LORATADINE, LORATADINE TABLET, FERROUS SULFATE, MELATONIN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, FISH OIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYBUTYNIN CHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 513 | 26848129 |
US |
2 | |
Somnolence, Gait disturbance, Decreased appetite, |
||||
FENFLURAMINE, |
||||
| 514 | 26848364 |
US |
60 | 2 |
Renal tubular necrosis, Fall, Tachycardia, Hypotension, Gait disturbance, Mental status changes, Drug interaction, |
||||
VALSARTAN, VALSARTAN ORAL, AMLODIPINE, EMPAGLIFLOZIN, |
||||
| 515 | 26848380 |
US |
1 | |
Hallucination, Oedema peripheral, Gait disturbance, Confusional state, |
||||
PIMAVANSERIN TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROXYZINE PAMOATE, ERGOCALCIFEROL, ALPRAZOLAM, |
||||
| 516 | 26848659 |
US |
87 | 2 |
Cerebrovascular accident, Hip surgery, Dementia, Arthropathy, Pain, Gait disturbance, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 517 | 26848933 |
CA |
1 | |
Gait disturbance, |
||||
BENRALIZUMAB, BENRALIZUMAB, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 518 | 26849213 |
US |
1 | |
Injection site pain, Pain in extremity, Hypersomnia, Gait disturbance, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 519 | 26849221 |
CA |
35 | |
Peripheral swelling, Anaphylactic reaction, Peripheral swelling, Pharyngeal swelling, Fatigue, Nausea, Gait disturbance, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, BUPROPION, MONTELUKAST, SERTRALINE, ALBUTEROL SULFATE, EPINEPHRINE, |
||||
| 520 | 26849241 |
CO |
40 | 2 |
Influenza, Paraesthesia, Gait disturbance, Pain in extremity, Burning sensation, Pain in jaw, Hyperaesthesia teeth, Blood triglycerides increased, |
||||
SATRALIZUMAB, ERGOCALCIFEROL, |
||||
| 521 | 26849268 |
US |
||
Gait disturbance, Arthralgia, |
||||
ESTRADIOL, ESTRADIOL, ESTRADIOL, ESTRADIOL, |
||||
| 522 | 26849326 |
CO |
87 | 1 |
Aortic occlusion, Peripheral artery occlusion, Contusion, Gait disturbance, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 523 | 26849459 |
US |
80 | 1 |
Hallucination, visual, Fall, Condition aggravated, Gait disturbance, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 524 | 26849793 |
US |
2 | |
Pneumonia, Foot amputation, Limb injury, Gait disturbance, Heart rate increased, Staphylococcal infection, Blood pressure measurement, Blood cholesterol, Pain in extremity, Anxiety, Wrong technique in device usage process, Extra dose administered, Product use issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 525 | 26849891 |
|||
Pain, Gait disturbance, Product use in unapproved indication, Product physical issue, Product ineffective for unapproved use, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 526 | 26850281 |
US |
2 | |
Asthenia, Gait disturbance, Dyspnoea exertional, Pain, Swelling, Musculoskeletal stiffness, Drug ineffective, |
||||
BELIMUMAB, |
||||
| 527 | 26850443 |
US |
82 | 1 |
Arthralgia, Gait disturbance, Balance disorder, Abdominal pain upper, Asthenia, Feeling abnormal, Illness, Pneumonia, Myocarditis, Cerebrovascular accident, Atrial thrombosis, Pain, Rash maculo-papular, Ejection fraction decreased, Rash, Hypersensitivity, Eosinophil count increased, Inflammation, |
||||
DUPILUMAB, MONTELUKAST SODIUM, |
||||
| 528 | 26850605 |
CA |
43 | 2 |
Confusional state, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Liver disorder, Lower limb fracture, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Pericarditis, Drug intolerance, Paraesthesia, Pemphigus, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Pyrexia, Rash, Rheumatoid arthritis, Rheumatoid factor positive, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound infection, Contraindicated product administered, Off label use, Product use in unapproved indication, |
||||
PREGABALIN, APREMILAST, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CALCIUM, CALCIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RISEDRONATE SODIUM, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TOFACITINIB CITRATE, TOFACITINIB CITRATE, VITAMIN C, ERGOCALCIFEROL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 529 | 26850820 |
MX |
69 | 2 |
Fatigue, Hypertension, Dyspnoea, Fibrosis, Gait disturbance, Condition aggravated, |
||||
MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, BISOPROLOL FUMARATE, |
||||
| 530 | 26851070 |
US |
67 | 1 |
Injection site haemorrhage, Muscular weakness, Gait disturbance, Arthralgia, Injection site bruising, |
||||
DUPILUMAB, |
||||
| 531 | 26851235 |
US |
77 | 2 |
Cardiac disorder, Food craving, Balance disorder, Gait disturbance, Product use issue, Arthritis, Glycosylated haemoglobin increased, Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, CLONAZEPAM, DULOXETINE HYDROCHLORIDE, |
||||
| 532 | 26851466 |
US |
2 | |
Pain in extremity, Gait disturbance, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 533 | 26851896 |
US |
79 | |
Dizziness, Gait disturbance, Weight decreased, Weight gain poor, Diarrhoea, Asthenia, |
||||
FECAL MICROBIOTA SPORES, LIVE-BRPK, FECAL MICROBIOTA SPORES, LIVE-BRPK, FECAL MICROBIOTA SPORES, LIVE-BRPK, LISINOPRIL, EZETIMIBE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, PANTOPRAZOLE, CARVEDILOL, CLONAZEPAM, MIRTAZAPINE, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, RAMELTEON, PERTUZUMAB, TRASTUZUMAB, |
||||
| 534 | 26851957 |
EU |
58 | 2 |
Syncope, Vision blurred, Hypersomnia, Pain in extremity, Gait disturbance, Arthralgia, Sciatica, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 535 | 26852004 |
JP |
85 | 2 |
Malignant neoplasm progression, Gait disturbance, Renal impairment, Hypophagia, Malaise, Nausea, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, TRASTUZUMAB, TRASTUZUMAB, OXALIPLATIN, OXALIPLATIN, |
||||
| 536 | 26852076 |
US |
||
Arthralgia, Chest pain, Rash, Gait disturbance, Renal impairment, Functional gastrointestinal disorder, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 537 | 26855069 |
77 | 1 | |
Gait disturbance, Tendonitis, Loss of personal independence in daily activities, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 538 | 26855576 |
76 | ||
Pyrexia, Pain, Arthralgia, Osteoarthritis, Gait disturbance, |
||||
ZOLEDRONIC ACID, DEXLANSOPRAZOLE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN, PANCRELIPASE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 539 | 26846375 |
AU |
1 | |
Cerebellar stroke, Cerebral hypoperfusion, Neuropathy peripheral, Abdominal distension, Balance disorder, Binocular eye movement disorder, Constipation, Depression, Diplopia, Dizziness, Dysarthria, Dysphonia, Feeling cold, Frustration tolerance decreased, Gait disturbance, Hyporesponsive to stimuli, Hypotension, Micturition urgency, Neuralgia, Nocturia, On and off phenomenon, Presyncope, Speech disorder, |
||||
PREGABALIN, RIVAROXABAN, SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE, NORTRIPTYLINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, FUROSEMIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, APOMORPHINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, RABEPRAZOLE SODIUM, RABEPRAZOLE, RASAGILINE MESYLATE, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, RIVAROXABAN, |
||||
| 540 | 26846376 |
AU |
1 | |
Cerebellar stroke, Cerebral hypoperfusion, Neuropathy peripheral, Abdominal distension, Balance disorder, Binocular eye movement disorder, Constipation, Depression, Diplopia, Dizziness, Dysarthria, Dysphonia, Feeling cold, Frustration tolerance decreased, Gait disturbance, General symptom, Hypotension, Micturition urgency, Neuralgia, Nocturia, Presyncope, Slow response to stimuli, Speech disorder, |
||||
PREGABALIN, NORTRIPTYLINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, FUROSEMIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, APOMORPHINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, RABEPRAZOLE SODIUM, RABEPRAZOLE, RASAGILINE MESYLATE, SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, RIVAROXABAN, |
||||
| 541 | 26846507 |
CO |
71 | 2 |
Anaemia, Weight decreased, Fall, Pain, Decreased appetite, Gait disturbance, |
||||
EVOLOCUMAB, |
||||
| 542 | 26846596 |
US |
68 | 2 |
Blood pressure abnormal, Gait disturbance, Dizziness, Fatigue, Asthenia, Headache, |
||||
ABATACEPT, |
||||
| 543 | 26846619 |
CA |
67 | 2 |
Catheter site erythema, Infusion site warmth, Muscle spasms, Musculoskeletal stiffness, Pain in extremity, Bradykinesia, Dyskinesia, Tremor, Mental fatigue, Fine motor skill dysfunction, Dizziness, Balance disorder, Catheter site discharge, Nausea, Vertigo, Catheter site erythema, Hallucination, auditory, Hallucination, visual, Nightmare, Infusion site discharge, Arthralgia, Infusion site bruising, Gait disturbance, Catheter site pain, Catheter site nodule, Pain in extremity, Gait inability, Therapeutic product effect incomplete, Memory impairment, Emotional disorder, Crying, Hypoaesthesia, Pain in extremity, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, |
||||
| 544 | 26849939 |
63 | 1 | |
Arthralgia, Tendon pain, Arthralgia, Asthenia, Gait disturbance, Malaise, |
||||
CIPROFLOXACIN HYDROCHLORIDE, FISH OIL, |
||||
| 545 | 26850128 |
63 | 2 | |
Blood sodium decreased, Blood potassium decreased, Product substitution issue, Therapeutic response decreased, Retching, Asthenia, Decreased appetite, Headache, Gait disturbance, Sensory disturbance, Dehydration, Vomiting, |
||||
| 546 | 26844938 |
US |
64 | 2 |
Skin discolouration, Scar, Fungal infection, Gait disturbance, Arthralgia, |
||||
DUPILUMAB, |
||||
| 547 | 26839791 |
US |
2 | |
Pyrexia, Gait disturbance, Adverse drug reaction, Sensory loss, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 548 | 26839801 |
IL |
77 | 1 |
Chest pain, On and off phenomenon, Dysstasia, Confusional state, Gait disturbance, Dizziness, Movement disorder, Feeding disorder, Condition aggravated, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, ESOMEPRAZOLE MAGNESIUM, ACYCLOVIR, DILTIAZEM HYDROCHLORIDE, BISOPROLOL FUMARATE, PREGABALIN, LEVETIRACETAM, |
||||
| 549 | 26839899 |
US |
76 | 1 |
Hip arthroplasty, Injury associated with device, Wrong technique in product usage process, Pain in extremity, Peripheral swelling, Gait disturbance, |
||||
EVOLOCUMAB, |
||||
| 550 | 26839935 |
US |
63 | 1 |
Parkinson^s disease, Freezing phenomenon, Loss of personal independence in daily activities, Gait disturbance, Tremor, Nausea, Drug effect less than expected, Therapy interrupted, Product use issue, Therapy cessation, |
||||
CARBIDOPA, CARBIDOPA TABLETS, LEVODOPA, PRAMIPEXOLE, ENTACAPONE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), SERTRALINE, HYDROXYZINE PAMOATE, |
||||
| 551 | 26839938 |
US |
||
Gait disturbance, Myalgia, Migraine, Sinus disorder, Back pain, |
||||
EVOLOCUMAB, |
||||
| 552 | 26839956 |
US |
2 | |
Neuropathy peripheral, Gait disturbance, Sciatica, Off label use, Erythema, Paraesthesia, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 553 | 26839979 |
CA |
||
Bone disorder, Bone loss, Gait disturbance, Joint stiffness, Loose tooth, Muscle spasticity, Neuralgia, Neuromyelitis optica spectrum disorder, Tooth loss, COVID-19, Gingivitis, Oral infection, Drug intolerance, |
||||
RITUXIMAB, SATRALIZUMAB, EMPAGLIFLOZIN, ERGOCALCIFEROL, |
||||
| 554 | 26840217 |
CA |
68 | 2 |
Laryngeal oedema, Cough, Insomnia, Gait disturbance, Pyrexia, |
||||
EVOLOCUMAB, |
||||
| 555 | 26840454 |
CA |
70 | |
Diverticulitis, Gait disturbance, Joint stiffness, General physical health deterioration, Musculoskeletal stiffness, Musculoskeletal pain, Pneumonia, Drug effect less than expected, |
||||
RITUXIMAB, RITUXIMAB, |
||||
| 556 | 26840505 |
US |
78 | 1 |
Delirium, Motor dysfunction, Neurological symptom, Balance disorder, Movement disorder, Delusion, Condition aggravated, Peripheral swelling, Gait disturbance, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 557 | 26840629 |
US |
2 | |
Gait disturbance, Loss of personal independence in daily activities, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALENDRONATE SODIUM, AMIODARONE HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BENZONATATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUPROPION HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FUROSEMIDE, GABAPENTIN, IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE, LORAZEPAM, LOSARTAN POTASSIUM, LOSARTAN, GUAIFENESIN 400 MG, GUAIFENESIN, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, ANTIMONY POTASSIUM TARTRATE, ATROPA BELLADONNA, BRYONIA ALBA WHOLE, ANEMONE AMERICANA, HYOSCYAMUS NIGER, IPECAC, LOBELIA INFLATA, HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED, AND LOBARIA PULMONARIA, DEXTROMETHORPHAN HBR, GUAIFENESIN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, GUAIFENESIN 400MG, MUCUS RELIEF, GUAIFENESIN 200 MG, OXYGEN, 0XYGEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CETIRIZINE HYDROCHLORIDE, |
||||
| 558 | 26840905 |
US |
74 | 2 |
Migraine, Musculoskeletal stiffness, Emotional distress, Crying, Retching, Gait disturbance, Confusional state, Dizziness, Vision blurred, Headache, Vomiting, Suspected off label use, Product administration error, |
||||
GABAPENTIN, |
||||
| 559 | 26841397 |
CA |
43 | 2 |
Folliculitis, Facet joint syndrome, Joint range of motion decreased, Impaired healing, Asthma, Peripheral swelling, Lung disorder, Fatigue, Deep vein thrombosis postoperative, Migraine, Musculoskeletal pain, Peripheral venous disease, Lower respiratory tract infection, Adjustment disorder with depressed mood, Night sweats, Lip dry, Autoimmune disorder, Bursitis, Chest pain, Irritable bowel syndrome, Dyspnoea, General physical health deterioration, Urticaria, Alopecia, Abdominal discomfort, Obesity, Inflammation, Confusional state, Gait disturbance, Gastrointestinal disorder, Blister, Hepatic enzyme decreased, Adverse drug reaction, Gait inability, Breast cancer stage II, Pulmonary fibrosis, Pneumonia, Depression, Condition aggravated, C-reactive protein abnormal, Stomatitis, Arthralgia, Blood cholesterol increased, Arthropathy, Infection, Dry mouth, Contusion, Osteoarthritis, Maternal exposure during pregnancy, Asthenia, Dyspepsia, Nausea, Anxiety, Muscle injury, Discomfort, Decreased appetite, Amnesia, Duodenal ulcer perforation, Paraesthesia, Exposure during pregnancy, Mobility decreased, Wound infection, Muscle spasms, Memory impairment, Weight increased, Ear pain, Grip strength decreased, Abdominal pain upper, Fibromyalgia, Delirium, Contraindicated product administered, Off label use, Incorrect route of product administration, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALENDRONATE SODIUM, CALCIUM CARBONATE, ANTACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEFLUNOMIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OXYCODONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CALCIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CELECOXIB, CERTOLIZUMAB PEGOL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 560 | 26841599 |
CA |
68 | |
Gait disturbance, Pain, Off label use, Underdose, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 561 | 26842067 |
US |
76 | 1 |
Illness, Gait disturbance, Musculoskeletal stiffness, Arthropathy, Drug ineffective, |
||||
SARILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CHROMIC CHLORIDE, CINNAMON, FINASTERIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NITROGLYCERIN, PREDNISONE, ROSUVASTATIN CALCIUM, ERGOCALCIFEROL, |
||||
| 562 | 26842346 |
EU |
31 | 2 |
Extrapyramidal disorder, Gait disturbance, Dyskinesia, |
||||
PALIPERIDONE, ZONISAMIDE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, PREGABALIN, |
||||
| 563 | 26842606 |
EU |
66 | 1 |
Muscular weakness, Fall, Gait disturbance, |
||||
LORAZEPAM, GABAPENTIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, OLANZAPINE, |
||||
| 564 | 26842689 |
US |
11 | 2 |
Self-destructive behaviour, Seizure, Freezing phenomenon, Condition aggravated, Abnormal behaviour, Gait disturbance, Dysstasia, General physical health deterioration, Vulvovaginal mycotic infection, Bacterial vaginosis, Stress, Bradykinesia, |
||||
TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, |
||||
| 565 | 26842799 |
CA |
80 | 2 |
Disorientation, Flat affect, Confusional state, Gait disturbance, Depression, Parkinsonism, Decreased appetite, Somnolence, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ERGOCALCIFEROL, RAMIPRIL, BISOPROLOL FUMARATE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, LANSOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 566 | 26843023 |
KR |
73 | 1 |
Acute kidney injury, Hyperkalaemia, Thrombocytopenia, Renal impairment, Thrombocytopenia, Pericarditis constrictive, Deep vein thrombosis, Pneumonia, Hyperkalaemia, Hyperkalaemia, Gastrooesophageal reflux disease, Dermatitis, Constipation, Anaemia, Hypoalbuminaemia, Decreased appetite, Gastritis, Dysphonia, Vocal cord paralysis, Gait disturbance, Cognitive disorder, Peripheral motor neuropathy, Hypoalbuminaemia, Leukocytosis, Haematuria, Pain in extremity, Oedema peripheral, Abdominal pain, Dyspnoea, |
||||
| 567 | 26843426 |
74 | 1 | |
Gait disturbance, Joint stiffness, Pleuritic pain, Hypophosphataemia, Hypophosphataemic osteomalacia, Arthralgia, |
||||
| 568 | 26843830 |
EU |
72 | 2 |
Joint swelling, Arthralgia, Gait disturbance, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 569 | 26844038 |
39 | 2 | |
Gait disturbance, Injection site swelling, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 570 | 26844533 |
CA |
1 | |
Neuromuscular blockade, Neurological symptom, Dysarthria, Dysphonia, Nasal congestion, Nasopharyngitis, Dysgeusia, Tooth infection, Abdominal pain upper, Dysphagia, Asthenia, Eyelid ptosis, Fatigue, Lacrimation increased, Cough, Rash, Hot flush, Insomnia, Nocturia, Muscular weakness, Mastication disorder, Gait disturbance, Gamma-glutamyltransferase increased, Therapeutic product effect incomplete, |
||||
RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, PYRIDOSTIGMINE BROMIDE, LISINOPRIL, DARIDOREXANT, |
||||
| 571 | 26844838 |
EU |
66 | 1 |
Muscular weakness, Fall, Gait disturbance, Hallucination, Dysarthria, Drug interaction, Off label use, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, OLANZAPINE, LORAZEPAM, GABAPENTIN, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, CALCIFEDIOL, BIMATOPROST, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, |
||||
| 572 | 26844909 |
EU |
67 | 2 |
Fall, Spinal pain, Arthralgia, Tremor, On and off phenomenon, Sleep disorder, Fatigue, Catheter site discharge, Musculoskeletal disorder, Movement disorder, Gait disturbance, Compression fracture, Gait inability, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, OPICAPONE, |
||||
| 573 | 26846553 |
45 | ||
Myalgia, Brain fog, Tremor, Dysstasia, Gait disturbance, Muscular weakness, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 574 | 26834494 |
US |
63 | 2 |
Psoriatic arthropathy, Psoriasis, Headache, Acne, Fatigue, Pain, Tremor, Sensitive skin, Varicella meningitis, Lumbar puncture, Hypersomnia, Vertigo, Gait disturbance, Sunburn, Hyperaesthesia eye, Insomnia, Loss of personal independence in daily activities, |
||||
UPADACITINIB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 575 | 26835045 |
US |
80 | |
Pain, Gait disturbance, Pain in extremity, Oedema peripheral, Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, FOLIC ACID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 576 | 26835049 |
EU |
76 | 1 |
Stoma site inflammation, Device dislocation, Musculoskeletal stiffness, Stoma site reaction, Movement disorder, Stoma site pain, Mobility decreased, On and off phenomenon, Gastrooesophageal reflux disease, Trismus, Nausea, Gait disturbance, Muscle rigidity, Overdose, Device physical property issue, Fibroma, Joint stiffness, Stoma site erythema, Restlessness, Choking, Incorrect dose administered, Dyskinesia, Stoma site pain, Device leakage, Stoma site discharge, Tension, Nocturia, Stoma site reaction, Stoma site induration, Tremor, Balance disorder, Reduced facial expression, Fatigue, Therapeutic product effect incomplete, Speech disorder, Asthenia, |
||||
PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 577 | 26835129 |
US |
||
Back pain, Gait disturbance, |
||||
EVOLOCUMAB, |
||||
| 578 | 26835218 |
CO |
45 | 2 |
Asthmatic crisis, Respiratory tract congestion, Dyspnoea, Influenza, Cough, Nasal congestion, Pain in extremity, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 579 | 26835231 |
US |
68 | 1 |
Gait disturbance, Dry eye, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 580 | 26835274 |
US |
83 | 2 |
Surgery, Pruritus, Rash macular, Gait disturbance, Product storage issue, Pain, Skin atrophy, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 581 | 26835321 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Autoimmune disorder, Back disorder, Blepharospasm, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Fluid retention, Folliculitis, Frequent bowel movements, Gait disturbance, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Intentional product misuse, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Laboratory test abnormal, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Myositis, Nail disorder, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Overlap syndrome, Pain, Pain in extremity, Pancreatitis, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Product quality issue, Product use in unapproved indication, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rectal haemorrhage, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, mixed type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapy non-responder, Type 2 diabetes mellitus, Underdose, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, White blood cell count increased, Wound, Wound infection, X-ray abnormal, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 582 | 26835342 |
UY |
65 | 1 |
Haemarthrosis, Abnormal weight gain, Haemophilic arthropathy, Walking aid user, Gait disturbance, |
||||
EMICIZUMAB, EMICIZUMAB, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 583 | 26835738 |
US |
1 | |
Lung disorder, Oxygen therapy, Gait disturbance, Back disorder, Productive cough, Dyspnoea, Feeling abnormal, Hospice care, |
||||
AMIKACIN, ALBUTEROL SULFATE, ALBUTEROL, AMOXICILLIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, UMECLIDINIUM, MELOXICAM, MIRTAZAPINE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, RIFABUTIN, ROFLUMILAST, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, |
||||
| 584 | 26835750 |
US |
81 | 1 |
Balance disorder, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 585 | 26836169 |
CO |
64 | 1 |
Blood potassium increased, Product use in unapproved indication, Palmoplantar keratoderma, Localised infection, Gait disturbance, |
||||
FINERENONE, |
||||
| 586 | 26836451 |
US |
79 | 2 |
Chronic obstructive pulmonary disease, Gait disturbance, Dyspnoea, Oxygen saturation decreased, Arthralgia, Product use in unapproved indication, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUDESONIDE, FOLIC ACID, FUROSEMIDE, ALBUTEROL SULFATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, IPRATROPIUM BROMIDE, ESOMEPRAZOLE MAGNESIUM, ROPINIROLE, SPIRONOLACTONE, ISOSORBIDE DINITRATE, |
||||
| 587 | 26836774 |
EU |
15 | 2 |
Encephalopathy, Facial paralysis, Akathisia, Cognitive disorder, Dysarthria, Salivary hypersecretion, Sedation, Nervous system disorder, Gait disturbance, Extrapyramidal disorder, Mania, Cogwheel rigidity, Drug ineffective, |
||||
OLANZAPINE, LITHIUM, LITHIUM BROMATUM, VALPROIC ACID, QUETIAPINE, |
||||
| 588 | 26837338 |
US |
60 | 2 |
Acute kidney injury, Renal tubular necrosis, Oliguria, Tachycardia, Gait disturbance, Drug interaction, |
||||
VALSARTAN, VALSARTAN ORAL, AMLODIPINE, EMPAGLIFLOZIN, |
||||
| 589 | 26837626 |
US |
59 | 2 |
Aortic arteriosclerosis, Spinal ligament ossification, Injection site reaction, Arthralgia, Back pain, Gait disturbance, Myalgia, Asthenia, Bone pain, Neck pain, Musculoskeletal stiffness, Joint range of motion decreased, Pain, Fatigue, Hypoaesthesia, Paraesthesia, Scoliosis, Intervertebral disc space narrowing, Facet joint syndrome, Osteoarthritis, Calcinosis, Blood glucose increased, Blood triglycerides increased, Vitamin D decreased, Loss of personal independence in daily activities, |
||||
ASFOTASE ALFA, |
||||
| 590 | 26837753 |
BR |
85 | 2 |
Vascular device infection, Acne, Dry skin, Nausea, Asthenia, Gait disturbance, Malaise, |
||||
PANITUMUMAB, VALSARTAN, VALSARTAN ORAL, |
||||
| 591 | 26837819 |
US |
72 | 1 |
Sepsis, Fall, Device issue, Gait disturbance, Fall, Device breakage, Catheter site pain, Catheter site injury, Catheter site infection, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 592 | 26837830 |
CA |
65 | 2 |
Neoplasm, Gait disturbance, |
||||
UPADACITINIB, |
||||
| 593 | 26838018 |
EU |
30 | 2 |
Coma, Miosis, Drug use disorder, Necrosis, Overdose, Gait disturbance, Speech disorder, Neurological decompensation, |
||||
OLANZAPINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ALPRAZOLAM, PREGABALIN, RIVAROXABAN, |
||||
| 594 | 26838034 |
75 | 1 | |
Skin cancer, Diabetes mellitus inadequate control, Prostatic specific antigen increased, Blood glucose increased, Dizziness, Asthenia, Fatigue, Depression, Post procedural infection, Herpes zoster, Chills, Localised infection, Anxiety, Brain fog, Tinnitus, Gait disturbance, Nausea, Peripheral swelling, Heart rate decreased, |
||||
DAROLUTAMIDE, RELUGOLIX, RELUGOLIX, RAMIPRIL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ALPRAZOLAM, CEFDINIR, EZETIMIBE, HYDROCHLOROTHIAZIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, TICAGRELOR, CIPROFLOXACIN HYDROCHLORIDE, INSULIN LISPRO, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, INSULIN GLARGINE, GABAPENTIN, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 595 | 26838043 |
45 | 1 | |
Gait disturbance, Dysarthria, Slow speech, Dizziness, Headache, Blood pressure increased, Heart rate increased, Blood magnesium increased, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, SERTRALINE, BUPROPION, |
||||
| 596 | 26838085 |
46 | 2 | |
Dysarthria, Dysphonia, Swelling face, Visual impairment, Facial paralysis, Fatigue, Gait disturbance, Dysuria, Dysphagia, Gastrointestinal motility disorder, Facial spasm, Discomfort, Facial paralysis, |
||||
ONABOTULINUMTOXINA, |
||||
| 597 | 26838395 |
US |
46 | 2 |
Hallucination, Mental impairment, Memory impairment, Cognitive disorder, Irritability, Mediastinal fibrosis, General physical health deterioration, Gait disturbance, Dysphagia, |
||||
TOPIRAMATE, TOPIRAMATE, DICHLORPHENAMIDE, |
||||
| 598 | 26838411 |
CA |
72 | 2 |
Deep brain stimulation, Catheter site related reaction, Catheter site bruise, Therapeutic product effect incomplete, Therapeutic product effect variable, Gait disturbance, Sinusitis, Catheter site nodule, Therapeutic product effect decreased, Feeling abnormal, Treatment noncompliance, Product prescribing error, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 599 | 26838430 |
EU |
85 | 1 |
Vitamin B complex deficiency, Limb discomfort, Gait disturbance, Musculoskeletal stiffness, Mobility decreased, Catheter site erythema, Catheter site induration, Device issue, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 600 | 26838653 |
CA |
74 | 2 |
Death, Blood pressure abnormal, Haemorrhage, Diarrhoea, Product dose omission issue, Gait disturbance, Dermatitis diaper, Malaise, Gastrointestinal disorder, Therapy interrupted, |
||||
APIXABAN, FUROSEMIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, PANTOPRAZOLE, IBRUTINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
